DRI Healthcare TrustTSX:DHT.UN +2.17%55 OCF Yield % is 16.05 as of Jul. 04, 2026, which is 41% below its 10-year median of 27.29. GuruFocus rates TSX:DHT.UN with a GF Score™ of 55/100 and a GF Value™ of C$18.68 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,007 Drug Manufacturers companies, DRI Healthcare Trust ranks better than 89.87% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
DRI Healthcare Trust OCF Yield % Related Terms
DRI Healthcare Trust OCF Yield % Historical Data
* Premium members only.
The historical data trend for DRI Healthcare Trust's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, DRI Healthcare Trust's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DRI Healthcare Trust OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DRI Healthcare Trust's OCF Yield % distribution charts can be found below:
* The bar in red indicates where DRI Healthcare Trust's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DRI Healthcare Trust (TSX:DHT.UN) has a OCF Yield % of 16.05 as of Jul. 04, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on DRI Healthcare Trust and its competitors. This is 41% below median its historical median of 27.29. Over the past decade, DRI Healthcare Trust's OCF Yield % has ranged from 11.27 to 49.31. According to the industry distribution chart, DRI Healthcare Trust ranks #102 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 10.1%.
Is DRI Healthcare Trust's OCF Yield % too high?
DRI Healthcare Trust's current OCF Yield % of 16.05 is 41% below median its 10-year median of 27.29. Over the past 10 years, this metric has ranged from a low of 11.27 to a high of 49.31. The Drug Manufacturers industry median OCF Yield % is 3.43. DRI Healthcare Trust's value of 16.05 is 367.9% above this industry median. Based on the distribution chart, DRI Healthcare Trust ranks #102 out of 1007 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, DRI Healthcare Trust has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DRI Healthcare Trust's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, DRI Healthcare Trust ranks #102 out of 1007 companies for OCF Yield %. This places DRI Healthcare Trust in the top 10% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.43. DRI Healthcare Trust's value of 16.05 is 367.9% above this benchmark. Historically, DRI Healthcare Trust's own OCF Yield % has ranged from 11.27 to 49.31 over the past decade. While the company's 10-year median is 27.29 vs. the industry median of 3.43, DRI Healthcare Trust has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.43, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DRI Healthcare Trust's current OCF Yield % of 16.05 is 367.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on DRI Healthcare Trust and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DRI Healthcare Trust's current OCF Yield % is 16.05, which is 41% below median its own 10-year median of 27.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DRI Healthcare Trust stock overvalued right now?
Based on GuruFocus' analysis, DRI Healthcare Trust (TSX:DHT.UN) is currently considered Fairly Valued. The stock's GF Value™ is C$18.68, compared to a current price of C$19.32 — trading 3.4% above its estimated fair value. The current OCF Yield % is 16.05, which is 41% below median its 10-year median of 27.29 and 367.9% above the Drug Manufacturers industry median of 3.43. DRI Healthcare Trust's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For DRI Healthcare Trust (TSX:DHT.UN), the current OCF Yield % is 16.05 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DRI Healthcare Trust (TSX:DHT.UN) Overvalued in 2026?
Based on GuruFocus' analysis, DRI Healthcare Trust stock appears to be overvalued.
The current stock price of C$19.32 is trading 3.4% above its estimated GF Value™ of C$18.68.
GuruFocus considers DRI Healthcare Trust to be Fairly Valued.
Key valuation signals for TSX:DHT.UN:
OCF Yield %: 16.05 (41% below median its 10-year median of 27.29)
GF Value™: C$18.68 vs. price of C$19.32 (3.4% above fair value)
Industry Position: 367.9% above the Drug Manufacturers median (#102 of 1007)
No single metric tells the full story. See the TSX:DHT.UN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DRI Healthcare Trust is an open-ended trust that purchases royalty entitlements on products that address unmet medical needs, providing its unitholders with top-line exposure to a portfolio of therapeutics. Its portfolio comprises several royalty streams on products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. The Trust has concluded that it operates as one segment, focused on acquiring royalty assets. Geographically, it generates maximum royalty income from the sale of products underlying its royalty agreements in the United States, followed by other markets such as Japan, the European Union, and the rest of the world.
55GF Score
Get the complete analysis for TSX:DHT.UN
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:DHT.UN has been successfully added to your 
